Ophthalmoscopic surveillance in treated patients with invasive Candida disease;Importancia de la vigilancia oftalmológica durante el tratamiento de la enfermedad invasora por Candida

Revista Iberoamericana de Micologia

Volumn 26, Issue 1, 2009, Pages 78-80

  Pérez Blázquez, Eugenio ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Candida; Candidiasis; Echinocandi; Endophthalmitis; Ocular findings; Ophthalmoscopic examination

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; VORICONAZOLE;

BLOOD CULTURE; BLURRED VISION; CANDIDA; CANDIDA ENDOPHTHALMITIS; CHILD HEALTH CARE; CHORIORETINITIS; CLINICAL FEATURE; CONSCIOUSNESS LEVEL; CRITICALLY ILL PATIENT; EARLY INTERVENTION; HUMAN; INVASIVE CANDIDIASIS; LENSECTOMY; MEDLINE; OPHTHALMOSCOPY; REVIEW; SYMPTOM; VISUAL SYSTEM EXAMINATION; VITRECTOMY; VITREOUS FLOATERS;

ADULT; CANDIDIASIS; CHILD; CHORIORETINITIS; CRITICAL ILLNESS; ENDOPHTHALMITIS; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEOPLASMS; NEUTROPENIA; OPHTHALMOSCOPY; PREVALENCE;

CANDIDA;

EID: 67650744501     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(09)70014-2     Document Type: Review

References (28)

1. Akler M.E., Vellend H., McNeely D.M., Walmsley S.L., and Gold W.L. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 20 (1995) 657-664
2. Baley J.E., and Ellis F.J. Neonatal candidiasis: ophthalmologic infection. Semin Perinatol 27 (2003) 401-405
3. Breit S.M., Hariprasad S.M., Mieler W.F., Shah G.K., Mills M.D., and Grand M.G. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 139 (2005) 135-140
4. Clinch T.E., Duker J.S., Eagle Jr. R.C., Calhoun J.H., and Augsburger J.J. Fischer DH. Infantile endogenous Candida endophthalmitis presenting as a cataract. Surv Ophthalmol 34 (1989) 107-112
5. Del Palacio A., Cuétara M.S., Ferro M., Pérez-Blázquez E., López-Saña J.A., Roiz M.P., Carnevali D., and Noriega A.R. Fluconazole in the management of endophthalmitis in disseminated candidosis of heroin addicts. Mycoses 36 (1993) 193-199
6. Donahue S.P., Hein E., and Sinatra R.B. Ocular involvement in children with candidemia. Am J Ophthalmol 135 (2003) 886-887
7. Enzenauer R.W., Calderwood S., Levin A.V., Elder J.E., and Morin J.D. Screening for fungal endophthalmitis in children at risk. Pediatrics 90 (1992) 451-457
8. Fisher R.G., Gary Karlowicz M., and Lall-Trail J. Very low prevalence of endophthalmitis in very low birthweight infants who survive candidemia. J Perinatol 25 (2005) 408-411
9. Gauthier G.M., Nork T.M., Prince R., and Andes D. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis 41 (2005) e27-e28
10. Groll A.H., Mickiene D., Petraitis V., Petraitiene R., Ibrahim K.H., Piscitelli S.C., Bekersky I., and Walsh T.J. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob Agents Chemother 45 (2001) 3322-3327
11. Kannangara S., Shindler D., Kunimoto D.Y., Sell B., and DeSimone J.A. Candidemia complicated by endophthalmitis: a prospective analysis. Eur J Clin Microbiol Infect Dis 26 (2007) 839-841
12. Karlowicz M.G., Giannone P.J., Pestian J., Morrow A.L., and Shults J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (≤ 1000 g) neonates?. Pediatrics 105 (2000) 1036-1040
13. Khan F.A., Slain D., and Khakoo R.A. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 27 (2007) 1711-1721
14. Krishna R., Amuh D., Lowder C.Y., Gordon S.M., Adal K.A., and Hall G. Should all patients with Candidaemia have an ophthalmic examination to rule out ocular candidiasis?. Eye 14 (2000) 30-34
15. Lamaris G.A., Esmaeli B., Chamilos G., Desai A., Chemaly R.F., Raad I.I., Safdar A., Lewis R.E., and Kontoyiannis D.P. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 27 (2008) 343-347
16. Maertens J. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Eur J Haematol 78 (2007) 275-282
17. Marangon F.B., Miller D., Giaconi J.A., and Alfonso E.C. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 137 (2004) 820-825
18. Noyola D.E., Bohra L., Paysse E.A., Fernandez M., and Coats D.K. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophthalmology 109 (2002) 80-84
19. Ohnishi Y., Tawara A., Murata T., Sakamoto T., Arakawa T., and Ishibashi T. Postmortem findings two weeks after oral treatment for metastatic Candida endophthalmitis with fluconazole. Ophthalmologica 213 (1999) 341-344
20. Pérez Blázquez E. Fondo de ojo en paciente crítico no neutropénico: endoftalmitis candidiásica. Rev Iberoam Micol 23 (2006) 16-19
21. Pontón J., and Del Palacio A. Avances y limitaciones del diagnóstico precoz de las infecciones invasoras causadas por levaduras. Rev Iberoam Micol 24 (2007) 181-186
22. Reboli A.C., Rotstein C., Pappas P.G., Chapman S.W., Kett D.H., Kumar D., Betts R., Wible M., Goldstein B.P., Schranz J., Krause D.S., Walsh T.J., and Anidulafungin Study Group. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356 (2007) 2472-2482
23. Rodríguez-Adrián L.J., King R.T., Tamayo-Derat L.G., Miller J.W., Garcia C.A., and Rex J.H. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine (Baltimore) 82 (2003) 187-202
24. Scherer W.J., and Lee K. Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis. Ophthalmology 104 (1997) 1593-1598
25. Smiddy W.E. Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol 9 (1998) 66-70
26. Suzuki T., Uno T., Chen G., and Ohashi Y. Ocular distribution of intravenously administered micafungin in rabbits. J Infect Chemother 14 (2008) 204-207
27. Virata S.R., Kylstra J.A., Brown J.C., Wohl D.A., and Cohen M.S. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B. Clin Infect Dis 28 (1999) 1177-1178
28. Zaoutis T.E., Greves H.M., Lautenbach E., Bilker W.B., and Coffin S.E. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis. J 23 (2004) 635-641